DSM and Novozymes confirm alliance

05-03-2008 | |

DSM Nutritional Products and Novozymes have restated their commitment to the feed market by renewing their strategic alliance agreement. With the renewal of the agreement, the two companies commit to further strengthening and developing their partnership.

The alliance has been proven successful since its beginning in 2001 and the
two partners look to launch a number of innovative, market-expanding and
promising products over the coming years. The DSM/Novozymes alliance is,
according to the company, a global market leader in feed enzymes.
“We are very pleased to reaffirm our commitment to the feed enzymes
alliance with Novozymes. Over the years, the alliance has been a driving force
in innovation and expansion of the global markets for animal feed enzymes. We
aim for better animal performance with less feed/better raw material
utilisation, while at the same time reducing environmental phosphates load and
contributing to our customers’ profitability by lowering the feed formulation
costs and we aim to continue this way”, says Leendert Staal, president of DSM
Nutritional Products.
“The alliance of DSM and Novozymes combines world leading competencies and
technologies of the two companies to deliver feed enzyme innovation to the
customers. We have some very interesting products in our pipeline which have
real potential to enable our customers to compensate for the fast rising grain
costs. Within the next two years, we expect to launch a new enzyme for corn-soy
diets and we have other products lined up for launch over the coming years”,
says Novozymes’ Executive Vice President Peder Holk Nielsen, who heads up the
company’s Enzymes Business.
The DSM/Novozymes alliance is an exclusive and global agreement. Under the
terms of the agreement, Novozymes develops and produces enzymes for animal feed
whereas DSM markets and sells the enzymes. The renewed alliance agreement covers
the principles of the alliance such as governance structure, supply and
distribution of products, intellectual property rights, profit sharing etc. The
agreement runs for the next five years.
Related links:


2/3 articles remaining | Register to continue reading.